Rosuvastatin Calcium Tablet, Film Coated
Product Images NDC 42677-301

8 FDA label images from Shandong New Time Pharmaceutical Co., Ltd. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 42677-301). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Shandong New Time Pharmaceutical Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Structure)

Image Description (Structure)
Chemical structure of Rosuvastatin Calcium, showing its molecular components including a fluorophenyl group, sulfonyl methyl group, hydroxyl groups, a carboxylate ion, and calcium ion (Ca2+) balancing the charge.*
FDA Label Image

Image Description (Figure 1)

Image Description (Figure 1)
A Kaplan-Meier cumulative incidence curve comparing Rosuvastatin Calcium (Rosuva) to placebo over 5 years, showing a lower cumulative incidence percentage for Rosuva. The graph includes a hazard ratio of 0.56 (95% CI 0.46-0.69) and a P-value less than 0.001, with a risk table indicating patient numbers over time for each group.*
FDA Label Image

Image Description (Figure 2)

Image Description (Figure 2)
A forest plot chart comparing the number of events between Rosuva 20 mg and placebo 20 mg groups across multiple cardiovascular endpoints. It shows hazard ratios with 95% confidence intervals and P values for each endpoint, including primary end point (MCE), cardiovascular death, nonfatal stroke, nonfatal myocardial infarction, hospitalized unstable angina, and arterial revascularization. The chart visually displays the relative risk and statistical significance of these events between the two groups.*
FDA Label Image

Image Description (Figure 3)

Image Description (Figure 3)
A box plot chart comparing the percent change from baseline in LDL cholesterol levels for different doses of lipid-lowering drugs including Crestor (rosuvastatin), Atorvastatin, Simvastatin, and Pravastatin. The x-axis shows doses in milligrams for each drug, and the y-axis shows percent change from baseline in LDL cholesterol, ranging from 0 to -75%.*
FDA Label Image

Image Description (5mg90ct)

Image Description (5mg90ct)
Rosuvastatin Tablets, USP 5 mg film-coated oral tablets, packaged in a carton with a quantity of 90 tablets. The label shows NDC 42577-301-01 and is marked Rx Only. The product is labeled by Shandong New Time Pharmaceutical Co., Ltd.*
FDA Label Image

Image Description (5mg500ct)

Image Description (5mg500ct)
Rosuvastatin Calcium tablets, USP 5 mg film-coated oral tablets label from Shandong New Time Pharmaceutical Co., Ltd. The label indicates 500 tablets per container, with FDA-required prescribing information including dosage and storage conditions. The package is marked Rx Only and features the company logo with NDC 42677-301-02.*
FDA Label Image

Image Description (10mg90ct)

Image Description (10mg90ct)
Rosuvastatin Tablets USP 10 mg film-coated tablets in a 90-tablet package. The label indicates prescription use only and is from Shandong New Time Pharmaceutical Co., Ltd. The label includes the NDC number 42677-302-01 and mentions the drug's dosage strength prominently in orange.*
FDA Label Image

Image Description (10mg500ct)

Image Description (10mg500ct)
Rosuvastatin Calcium 10 mg film-coated tablets carton label from Shandong New Time Pharmaceutical Co., Ltd. The label specifies 10 mg strength and a package size of 500 tablets. It includes storage instructions and prescription information, stating the tablets contain rosuvastatin calcium equivalent to 10 mg rosuvastatin.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.